Recent trends in incidence of five common cancers in 26 European countries since 1988: Analysis of the European Cancer Observatory

Published:October 10, 2013DOI:



      Individual country- and cancer site-specific studies suggest that the age-adjusted incidence of many common cancers has increased in European populations over the past two decades. To quantify the extent of these trends and the recent burden of cancer, here we present a comprehensive overview of trends in population-based incidence of the five common cancers across Europe derived from a new web-based portal of the European cancer registries.


      Data on incidence for cancers of the colon and rectum, prostate, breast, corpus uteri and stomach diagnosed from 1988 to 2008 were obtained from the European Cancer Observatory for cancer registries from 26 countries. Annual age-standardised incidence rates and average annual percentage changes were calculated.


      Incidence of four common cancers in eastern and central European countries (prostate, postmenopausal breast, corpus uteri and colorectum) started to approach levels in northern and western Europe, where rates were already high in the past but levelled off in some countries in recent years. Decreases in stomach cancer incidence were seen in all countries.


      Increasing trends in incidence of the most common cancers, except stomach cancer, are bad news to public health but can largely be explained by well-known changes in society in the past decades. Thus, current and future efforts in primary cancer prevention should not only remain focussed on the further reduction of smoking but engage in the long-term efforts to retain healthy lifestyles, especially avoiding excess weight through balanced diets and regular physical exercise.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • WHO
        The global burden of disease: 2004 update.
        World Health Organization, Geneva2004 (2008)
        • Parkin D.M.
        The evolution of the population-based cancer registry.
        Nat Rev Cancer. 2006; 6: 603-612
        • Znaor A.
        • van den Hurk C.
        • Primic-Zakelj M.
        • Agius D.
        • Coza D.
        • Demetriou A.
        • et al.
        Cancer incidence and mortality patterns in South Eastern Europe in the last decade: gaps persist compared with the rest of Europe.
        Eur J Cancer. 2013; 49: 1683-1691
        • Martin-Moreno J.M.
        • Soerjomataram I.
        • Magnusson G.
        Cancer causes and prevention: a condensed appraisal in Europe in 2008.
        Eur J Cancer. 2008; 44: 1390-1403
        • Soerjomataram I.
        • de Vries E.
        • Pukkala E.
        • Coebergh J.W.
        Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change.
        Int J Cancer. 2007; 120: 1336-1343
        • Gilmore A.
        • Pomerleau J.
        • McKee M.
        • Rose R.
        • Haerpfer C.W.
        • Rotman D.
        • et al.
        Prevalence of smoking in 8 countries of the former Soviet Union: results from the living conditions, lifestyles and health study.
        Am J Public Health. 2004; 94: 2177-2187
        • Graham H.
        Smoking prevalence among women in the European Community 1950–1990.
        Soc Sci Med. 1996; 43: 243-254
        • Janssen-Heijnen M.L.
        • Coebergh J.W.
        The changing epidemiology of lung cancer in Europe.
        Lung Cancer. 2003; 41: 245-258
      1. WHO. Mean body mass index (BMI): situation and trends. In: Global health observatory (GHO); 2013.

        • Renehan A.G.
        • Soerjomataram I.
        • Tyson M.
        • Egger M.
        • Zwahlen M.
        • Coebergh J.W.
        • et al.
        Incident cancer burden attributable to excess body mass index in 30 European countries.
        Int J Cancer. 2010; 126: 692-702
        • McCormack V.A.
        • Boffetta P.
        Today’s lifestyles, tomorrow’s cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries.
        Ann Oncol. 2011; 22: 2349-2357
        • Karim-Kos H.E.
        • de Vries E.
        • Soerjomataram I.
        • Lemmens V.
        • Siesling S.
        • Coebergh J.W.
        Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.
        Eur J Cancer. 2008; 44: 1345-1389
      2. Steliarova-Foucher E, O’Callaghan M, Ferlay J, Masuyer E, Forman D, Comber H, et al. European cancer observatory: cancer incidence, mortality, prevalence and survival in Europe. In. September 2012 ed.: European Network of Cancer Registries, International Agency for Research on Cancer.

        • Curado M.P.
        • Edwards B.
        • Shin H.R.
        • Storm H.
        • Ferlay J.
        • Heanue M.
        • et al.
        Cancer incidence in five continents. vol. IX. IARC Sci. Publ., Lyon2007
        • Ferlay J.
        • Steliarova-Foucher E.
        • Lortet-Tieulent J.
        • Rosso S.
        • Coebergh J.W.
        • Comber H.
        • et al.
        Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.
        Eur J Cancer. 2013; 49: 1374-1403
        • Thomas F.
        • Renaud F.
        • Benefice E.
        • De Meeus T.
        • Guegan J.F.
        International variability of ages at menarche and menopause: patterns and main determinants.
        Hum Biol. 2001; 73: 271-290
        • Giordano L.
        • von Karsa L.
        • Tomatis M.
        • Majek O.
        • de Wolf C.
        • Lancucki L.
        • et al.
        Mammographic screening programmes in Europe: organization, coverage and participation.
        J Med Screen. 2012; 19: 72-82
        • Hakama M.
        • Coleman M.P.
        • Alexe D.M.
        • Auvinen A.
        Cancer screening: evidence and practice in Europe 2008.
        Eur J Cancer. 2008; 44: 1404-1413
        • de Vries E.
        • Soerjomataram I.
        • Lemmens V.E.
        • Coebergh J.W.
        • Barendregt J.J.
        • Oenema A.
        • et al.
        Lifestyle changes and reduction of colon cancer incidence in Europe: a scenario study of physical activity promotion and weight reduction.
        Eur J Cancer. 2010; 46: 2605-2616
      3. American Institute for Cancer Research, World Cancer Research Fund. Continuous update project report. Food, nutrition, physical activity, and the prevention of breast cancer; 2010.

      4. Collaborative Group on Hormonal Factors in Breast Cancer, Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118964 women with breast cancer from 117 epidemiological studies.
        Lancet Oncol. 2012; 13: 1141-1151
        • Terry M.B.
        • Zhang F.F.
        • Kabat G.
        • Britton J.A.
        • Teitelbaum S.L.
        • Neugut A.I.
        • et al.
        Lifetime alcohol intake and breast cancer risk.
        Ann Epidemiol. 2006; 16: 230-240
        • Bagnardi V.
        • Rota M.
        • Botteri E.
        • Tramacere I.
        • Islami F.
        • Fedirko V.
        • et al.
        Light alcohol drinking and cancer: a meta-analysis.
        Ann Oncol. 2013; 24: 301-308
        • Lahmann P.H.
        • Friedenreich C.
        • Schuit A.J.
        • Salvini S.
        • Allen N.E.
        • Key T.J.
        • et al.
        Physical activity and breast cancer risk: the European prospective investigation into cancer and nutrition.
        Cancer Epidemiol Biomark Prev. 2007; 16: 36-42
        • Shantakumar S.
        • Terry M.B.
        • Teitelbaum S.L.
        • Britton J.A.
        • Millikan R.C.
        • Moorman P.G.
        • et al.
        Reproductive factors and breast cancer risk among older women.
        Breast Cancer Res Treat. 2007; 102: 365-374
      5. Collaborative Group on Hormonal Factors in Breast Cancer, Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease.
        Lancet. 2002; 360: 187-195
        • Stattin P.
        • Johansson R.
        • Damber J.E.
        • Hellstrom M.
        • Hugosson J.
        • Lundgren R.
        • et al.
        Non-systematic screening for prostate cancer in Sweden – survey from the National Prostate Cancer Registry.
        Scand J Urol Nephrol. 2003; 37: 461-465
        • Schroder F.H.
        • Hugosson J.
        • Roobol M.J.
        • Tammela T.L.
        • Ciatto S.
        • Nelen V.
        • et al.
        Prostate-cancer mortality at 11 years of follow-up.
        N Engl J Med. 2012; 366: 981-990
        • Andriole G.L.
        • Crawford E.D.
        • Grubb 3rd, R.L.
        • Buys S.S.
        • Chia D.
        • Church T.R.
        • et al.
        Mortality results from a randomized prostate-cancer screening trial.
        N Engl J Med. 2009; 360: 1310-1319
        • Andriole G.L.
        • Crawford E.D.
        • Grubb 3rd, R.L.
        • Buys S.S.
        • Chia D.
        • Church T.R.
        • et al.
        Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
        J Natl Cancer Inst. 2012; 104: 125-132
        • Kilpelainen T.P.
        • Tammela T.L.
        • Malila N.
        • Hakama M.
        • Santti H.
        • Maattanen L.
        • et al.
        Prostate cancer mortality in the finnish randomized screening trial.
        J Natl Cancer Inst. 2013; 105: 719-725
        • Evans T.
        • Sany O.
        • Pearmain P.
        • Ganesan R.
        • Blann A.
        • Sundar S.
        Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006.
        Br J Cancer. 2011; 104: 1505-1510
        • Boll D.
        • Karim-Kos H.E.
        • Verhoeven R.H.A.
        • Burger C.W.
        • Coebergh J.W.
        • van de Poll-Franse L.V.
        • et al.
        Increased incidence and improved survival in endometrioid endometrial cancer diagnosed since 1989 in The Netherlands: a population based study.
        Eur J Obstet Gynecol Reprod Biol. 2013; 166: 209-214
        • Stang A.
        Impact of hysterectomy on the age-specific incidence of cervical and uterine cancer in Germany and other countries.
        Eur J Public Health. 2012; ([Epub ahead of print])
        • Luoto R.
        • Raitanen J.
        • Pukkala E.
        • Anttila A.
        Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953–2010.
        Br J Cancer. 2004; 90: 1756-1759
        • Forman D.
        • Burley V.J.
        Gastric cancer: global pattern of the disease and an overview of environmental risk factors.
        Best Pract Res Clin Gastroenterol. 2006; 20: 633-649
        • Crew K.D.
        • Neugut A.I.
        Epidemiology of gastric cancer.
        World J Gastroenterol. 2006; 12: 354-362
        • de Martel C.
        • Forman D.
        • Plummer M.
        Gastric cancer: epidemiology and risk factors.
        Gastroenterol Clin North Am. 2013; 42: 219-240
        • Soerjomataram I.
        • de Vries E.
        • Lemmens V.E.P.P.
        • Coebergh J.W.W.
        • Barendregt J.J.
        • Oenema A.
        • et al.
        Lifestyle changes and reduction of colon cancer incidence in Europe: a scenario study of physical activity promotion and weight reduction.
        Eur J Cancer. 2010; 46: 2605-2616
        • Dallat M.A.
        • Soerjomataram I.
        • Hunter R.F.
        • Tully M.A.
        • Cairns K.J.
        • Kee F.
        Urban greenways have the potential to increase physical activity levels cost-effectively.
        Eur J Public Health. 2013; ([Epub ahead of print])
        • Draisma G.
        • Etzioni R.
        • Tsodikov A.
        • Mariotto A.
        • Wever E.
        • Gulati R.
        • et al.
        Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context.
        J Natl Cancer Inst. 2009; 101: 374-383
        • Marmot M.G.
        • Altman D.G.
        • Cameron D.A.
        • Dewar J.A.
        • Thompson S.G.
        • Wilcox M.
        • et al.
        The Independent UK Panel on Breast Cancer Screening, The benefits and harms of breast cancer screening: an independent review.
        Br J Cancer. 2013; 108: 2205-2240
        • Puliti D.
        • Duffy S.W.
        • Miccinesi G.
        • de Koning H.
        • Lynge E.
        • Zappa M.
        • et al.
        Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review.
        J Med Screen. 2012; 19: 42-56
        • Welch H.G.
        • Schwartz L.M.
        • Woloshin S.
        Are increasing 5-year survival rates evidence of success against cancer?.
        JAMA. 2000; 283: 2975-2978
        • Malvezzi M.
        • Bertuccio P.
        • Levi F.
        • La Vecchia C.
        • Negri E.
        European cancer mortality predictions for the year 2013.
        Ann Oncol. 2013; 24: 792-800
        • La Vecchia C.
        • Bosetti C.
        • Lucchini F.
        • Bertuccio P.
        • Negri E.
        • Boyle P.
        • et al.
        Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975.
        Ann Oncol. 2010; 21: 1323-1360
        • Soerjomataram I.
        • Lortet-Tieulent J.
        • Parkin D.M.
        • Ferlay J.
        • Mathers C.
        • Forman D.
        • et al.
        Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.
        Lancet. 2012; 380: 1840-1850
        • Coebergh J.W.
        • Martin-Moreno J.M.
        • Soerjomataram I.
        • Renehan A.G.
        The long road towards cancer prevention: 4 steps backward and 8 forward.
        Eur J Cancer. 2010; 46: 2660-2662
      6. American Institute for Cancer Research, World Cancer Research Fund. Food, nutrition, physical activity and the prevention of cancer: a global perspective: a project of World Cancer Research Fund International. Washington, D.C.: American Institute for Cancer Research; 2007.

      7. American Institute for Cancer Research, World Cancer Research Fund. Continuous Update Project Report. Food, nutrition, physical activity, and the prevention of colorectal cancer; 2011.

      8. OECD. Health at a Glance: Europe 2012; 2012.

        • Hannan L.M.
        • Jacobs E.J.
        • Thun M.J.
        The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States.
        Cancer Epidemiol Biomark Prev. 2009; 18: 3362-3367
        • Hartz A.J.
        • He T.
        Cohort study of risk factors for breast cancer in post menopausal women.
        Epidemiol Health. 2013; 35: e2013003
        • Brown I.J.
        • Tzoulaki I.
        • Candeias V.
        • Elliott P.
        Salt intakes around the world: implications for public health.
        Int J Epidemiol. 2009; 38: 791-813
      9. EC. Survey on members states’ implementation of the EU salt reduction framework: European Commission. Directorate-General Health and Consumers; 2012.

      10. CBS. Gezondheid, leefstijl, zorggebruik; t/m 2009. In: Statistics Netherlands. Statline Database; 2010.

      11. NHS. Statistics on obesity, physical activity and diet: England, 2010. The Health and Social Care Information Centre; 2010.

      12. SCB. Outdoor activities and exercise by indicator, age and sex. Percentage and estimated numbers in thousands. Year 2008–2009 – 2010–2011. In: Statistics Sweden; 2012.

        • Soerjomataram I.
        • Pukkala E.
        • Brenner H.
        • Coebergh J.W.
        On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk.
        Breast Cancer Res Treat. 2008; 111: 297-302
        • Soerjomataram I.
        • Coebergh J.W.
        • Louwman M.W.
        • Visser O.
        • van Leeuwen F.E.
        Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands?.
        J Clin Oncol. 2007; 25 (author reply 5039–40): 5038-5039
        • Katalinic A.
        • Rawal R.
        Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy.
        Breast Cancer Res Treat. 2008; 107: 427-430
        • Parkin D.M.
        Is the recent fall in incidence of post-menopausal breast cancer in UK related to changes in use of hormone replacement therapy?.
        Eur J Cancer. 2009; 45: 1649-1653
        • Bray F.
        • Loos A.H.
        • Oostindier M.
        • Weiderpass E.
        Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe.
        Int J Cancer. 2005; 117: 123-131
      13. Eurostat. Live births by mother’s age at last birthday and legal marital status. In: European Commission; 2013.

        • Yngve A.
        • Sjostrom M.
        Breastfeeding in countries of the European Union and EFTA: current and proposed recommendations, rationale, prevalence, duration and trends.
        Public Health Nutr. 2001; 4: 631-645
        • Kumle M.
        Declining breast cancer incidence and decreased HRT use.
        Lancet. 2008; 372: 608-610
        • Mourad-Baars P.E.
        • Verspaget H.W.
        • Mertens B.J.
        • Mearin M.L.
        Low prevalence of Helicobacter pylori infection in young children in the Netherlands.
        Eur J Gastroenterol Hepatol. 2007; 19: 213-216
      14. von Karsa L, Anttila A, Ronco G, Ponti A, Malila N, Arbyn M, et al. Cancer Screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. European Commission; 2007.

        • Church T.R.
        Screening for colorectal cancer – which strategy is the best?.
        J Natl Cancer Inst. 2011; 103: 1282-1283
        • Mandel J.S.
        • Church T.R.
        • Bond J.H.
        • Ederer F.
        • Geisser M.S.
        • Mongin S.J.
        • et al.
        The effect of fecal occult-blood screening on the incidence of colorectal cancer.
        N Engl J Med. 2000; 343: 1603-1607
        • Baade P.D.
        • Youlden D.R.
        • Krnjacki L.J.
        International epidemiology of prostate cancer: geographical distribution and secular trends.
        Mol Nutr Food Res. 2009; 53: 171-184
        • Levi F.
        • Te V.C.
        • Maspoli M.
        • Randimbison L.
        • Bulliard J.L.
        • La Vecchia C.
        Trends in breast cancer incidence among women under the age of forty.
        Br J Cancer. 2007; 97: 1013-1014
        • Stang A.
        • Pukkala E.
        • Sankila R.
        • Soderman B.
        • Hakulinen T.
        Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases.
        Int J Cancer. 2006; 119: 380-384
        • Lortet-Tieulent J.
        • Renteria E.
        • Sharp L.
        • Weiderpass E.
        • Comber H.
        • Baas P.
        Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010.
        Eur J Cancer. 2015; 51: 1144-1163